TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-48.76%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - P/B ratio
P/B ratio as of April 2024 : 0.7688
According to TherapeuticsMD's latest financial reports the company has a price-to-book ratio of 0.7688.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
TherapeuticsMD - P/B ratio (from 2003 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.8482 | -43.67% |
| 2022-12-31 | 1.51 | -193.33% |
| 2021-12-31 | -1.61 | -44.84% |
| 2020-12-31 | -2.93 | -104.1% |
| 2019-12-31 | 71.3 | 659.22% |
| 2018-12-31 | 9.39 | -6.64% |
| 2017-12-31 | 10.1 | 13.1% |
| 2016-12-31 | 8.90 | -69.59% |
| 2015-12-31 | 29.3 | 103.82% |
| 2014-12-31 | 14.4 | 3.96% |
| 2013-12-31 | 13.8 | -106.4% |
| 2012-12-31 | -216 | 203.35% |
| 2011-12-31 | -71.2 | -13455.09% |
| 2010-12-31 | 0.5328 | -100.81% |
| 2009-12-31 | -66.0 | -180.8% |
| 2008-12-31 | 81.7 | 6433.54% |
| 2007-12-31 | 1.25 | 91.34% |
| 2006-12-31 | 0.6533 | 3.86% |
| 2005-12-31 | 0.6291 | 17.14% |
| 2004-12-31 | 0.5370 | -25.41% |
| 2003-12-31 | 0.7200 | |
| 2002-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.61 | 109.45% | 🇺🇸 USA |
 AbbVie ABBV | 27.2 | 3,436.02% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -0.2210 | -128.74% | 🇺🇸 USA |
 Royalty Pharma RPRX | 1.66 | 115.78% | 🇬🇧 UK |
 Lannett Company LCI | -0.0179 | -102.33% | 🇺🇸 USA |